Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 25.2.2010-11.3.2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP Certified
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- in vitro gene mutation study in bacteria
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- in vitro gene mutation study in bacteria
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
Reference
- Name:
- Unnamed
- Type:
- Constituent
- Specific details on test material used for the study:
- Identification: Magnesium hydroxide
Molecular Formula: Mg(OH)2
Molecular weight: 58.32
Method
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver microsomal enzymes were routinely prepared from adult male Wistar rats
- Test concentrations with justification for top dose:
- In the dose range finding test, Magnesium hydroxide was tested up to concentrations of 5000 µg/plate. Based on these results Magnesium hydroxide was tested in the first mutation assay at a concentration range of 100 to 5000 µg/plate. In an independent repeat of the assay, Magnesium hydroxide was tested at the same concentration range as the first assay.
- Vehicle / solvent:
- DMSO
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Dimethyl sulfoxide
- Positive controls:
- yes
- Positive control substance:
- other:
- Details on test system and experimental conditions:
- Test system: Salmonella typhimurium bacteria and Escherichia coli bacteria.
The Salmonella typhimurium strains were regularly checked to confirm their histidine-requirement, crystal violet senesitivity, ampicillin resistance (TA98 and TA100), UV-sensitivity and the number of spontaneous revertants.
The Escherichia coli WP2uvrA strain was regularly checked to confirm the tryptophan-requirement, UV-sensitivity and the number of spontaneous revertants.
Stock cultures of the five strains were stored in liquid nitrogen (-196°C). - Evaluation criteria:
- No formal hypothesis testing was done.
A test substance is considered negative (not mutagenic) in the test if:
a) The total number of revertants in tester strain TA100 is not greater than two (2) times the concurrent control, and the total number of revertants in tester strains TA1535, TA1537, TA98 or WP2uvrA is not greater than three (3) times the concurrent control.
b) The negative response should be reproducible in at least one independently repeated experiment.
A test substance is considered positive (mutagenic) in the test if:
a) The total number of revertants in tester strain TA100 is greater than two (2) time the concurrent control, or the total number of revertants in tester strains TA1535, TA1537, TA98 or WP2uvrA is greater than three (3) time the concurrent control.
b) In case a repeat experiment is performed when a positive response is observed in one of the tester strains, the positive response should be reproducible in at least one independently repeated experiment.
The preceding criteria were not absolute and other modifying factors might enter into the final evaluation decision.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
Any other information on results incl. tables
Dose range finding test
Magnesium hydroxide was tested in the tester strains TA100 and WP2uvrA with concentrations of 3,10, 33, 100, 333, 1000, 3330, and 5000 µg/plate in the absence and presence of S9-mix.
Table 1. Strain TA100 - Without S9 -mix
Plate Dose (micrograms/plate) |
1 |
2 |
3 |
Mean |
SD |
Positive control |
1039 |
990 |
983 |
1004± |
31 |
Solvent control |
99 |
94 |
112 |
102± |
9 |
3 |
95 |
87 |
85 |
89 ± |
5 |
10 |
84 |
101 |
86 |
90± |
9 |
33 |
123 |
139 |
107 |
123 ± |
16 |
100 |
106 |
100 |
94 |
100 ± |
6 |
333 |
111 |
110 |
108 |
110 ± |
2 |
1000 |
87 |
95 |
109 |
97 ± |
11 |
3330 |
84 |
106 |
84 |
91 ± |
13 |
5000 |
175 |
111 |
101 |
129 ± |
40 |
Table 2. Strain TA100 With S9 -mix
Plate Dose (micrograms/plate) |
1 |
2 |
3 |
Mean |
SD |
Positive control |
1283 |
1347 |
1240 |
1290± |
54 |
Solvent control |
156 |
134 |
126 |
139± |
16 |
3 |
96 |
65 |
66 |
76± |
18 |
10 |
71 |
83 |
95 |
83± |
12 |
33 |
84 |
80 |
112 |
92± |
17 |
100 |
95 |
107 |
99 |
100± |
6 |
333 |
107 |
99 |
93 |
100± |
7 |
1000 |
102 |
86 |
94 |
94± |
8 |
3330 |
108 |
100 |
97 |
102± |
6 |
5000 | 95 | 139 | 105 | 113± | 23 |
No precipitation of Magnesium Hydroxide was observed on the plates at start or end of incubation period.
No reduction of the bacterial lawn and no biologically relevant decrease in the number of revertants were observed.
No increase in the number of revertants was observed upon treatment with Magnesium hydroxide under all conditions tested.
Mutation assay
Magnesium hydroxide was tested in the absense and presence of S9 -mix in two mutation assays. The first experiment was performed with the strains TA1535, TA1537 and TA98 and the second mutation was performed with strains TA1535, TA1537, TA98, TA100 andWP2uvrA. Results are in the tables below.
Table 3. Experiment 1: Mutagenic response of Magnesium hydorxide inSalmonella typhimuriumreverse mutation assay and in theEscherichia colirevers mutation assay.
Dose (µg/plate) |
Mean number of revertant colonies/3 replicate plates (± S.D.) with different strains ofSalmonells typhimuriumand oneEscherichia colistrain |
||||
TA1535 |
TA1537 |
TA98 |
TA100 |
WP2uvrA |
|
Without S9 -mix |
|||||
positive control |
857±14 |
343±11 |
982±89 |
1004±31 |
513± 1 |
solvent control |
6± 2 |
3±1 |
12±1 |
102±9 |
21±4 |
|
|
|
|
|
|
3 |
|
|
|
89±5 |
19±5 |
10 |
|
|
|
90±9 |
18±3 |
33 |
|
|
|
123±16 |
23±2 |
100 |
7±2 |
3±1 |
16±3 |
100±6 |
16±6 |
333 |
6±1 |
3±1 |
12±1 |
110±2 |
20±2 |
1000 |
5±1 |
4±1 |
14±5 |
97±11 |
18±4 |
3330 |
7±1 |
4±2 |
14±1 |
91±13 |
24±7 |
5000 |
8±1 |
3±0 |
16±3 |
129±40 |
25±3 |
With S9 -mix |
|||||
positive control |
155±11 |
300±31 |
940± 21 |
1290±54 |
282±20 |
solvent control |
6±1 |
3±0 |
17±3 |
139±16 |
17±5 |
|
|
|
|
|
|
3 |
|
|
|
76±18 |
18±2 |
10 |
|
|
|
83±12 |
18±5 |
33 |
|
|
|
92±17 |
17±3 |
100 |
8± 1 |
3±0 |
21±7 |
100±6 |
16±4 |
333 |
6±3 |
4±1 |
17± 1 |
100±7 |
23±2 |
1000 |
6±2 |
3±1 |
14±4 |
94±8 |
19±5 |
3330 |
7±1 |
3±0 |
17±3 |
102±6 |
23±3 |
5000 |
8±2 |
5±1 |
13±1 |
113±23 |
23±3 |
Table 4. Experiment 2: Mutagenic response of Magnesium hydroxide in theSalmonella typhimuriumreverse mutation assay and inEscherichia colireverse mutation assay.
Dose (µg/plate) |
Mean number of reverant colonies/3 replicate plates (±S.D.) with different strains ofSalmonella typhimuriumand oneEscherichia colistrain |
||||
TA1535 |
TA1537 |
TA98 |
TA100 |
WP2uvrA |
|
Without S9 -mix |
|||||
positive control |
735± 16 |
312±40 |
1109±31 |
958± 24 |
952±27 |
solvent control |
9±2 |
3±0 |
18±3 |
104±6 |
19±4 |
|
|
|
|
|
|
100 |
9±2 |
3±1 |
15±2 |
96±6 |
21±3 |
333 |
8±1 |
3±0 |
16±5 |
106±13 |
21±3 |
1000 |
6±1 |
6±1 |
19±4 |
98±4 |
21±3 |
3330 |
7±1 |
3±1 |
15±4 |
101±6 |
24±3 |
5000 |
7±3 |
3±0 |
14±3 |
103±10 |
22±4 |
With S9 -mix |
|||||
positive control |
125±18 |
368±8 |
669±33 |
745±48 |
176±18 |
solvent control |
4±1 |
3±0 |
19±2 |
61±2 |
20±4 |
|
|
|
|
|
|
100 |
7±4 |
3±1 |
18±1 |
66±5 |
20±4 |
333 |
7±1 |
3±0 |
22±4 |
68±3 |
21±4 |
1000 |
6±2 |
3±1 |
21±3 |
65±7 |
18± 2 |
3330 |
7±2 |
3±0 |
19±4 |
80±6 |
30±5 |
5000 |
7±3 |
4±2 |
19±3 |
105±6 |
28± 2 |
Precipitation of Magnesium hydroxide on the plates was not observed at the start or at the end of the incubation period.
In both mutation assays, there was no reduction of the bacterial background lawn and no biologically relevant decrease in the number of revertants at any of the concentrations tested in all tester strains in the absence and presence of S9 -mix.
In both assays, no increase in the number of revertants was observed upon treatment with Magnesium hydroxide under all conditions tested.
Applicant's summary and conclusion
- Conclusions:
- All bacteria strains showed negative responses over the entire dose range, i.e. no significant dose-related increase in the number of revertants in two repeated experiments.
The negative strain-specific positive control values were within the laboratory historical control data ranges indicating that the test conditions were adequate and that the metabolic activation system functioned properly.
Based on the results of this study it is concluded that Magnesium hydroxide is not mutagenic in the Salmonella typhimurium reverse mutation assay and in the Escherichia coli reverse mutation assay. - Executive summary:
Evaluation of the mutagenic activity of Magnesium hydroxide in theSalmonella typhimuriumreverse mutation assay and theEscherichia colireverse mutation assay (with independent repeat).
Magnesium hydroxide was tested in theSalmonella typhimuriumreverse mutation assay with four histidine-requiring strains ofSalmonella typhimurium(TA1535, TA1537, TA98 and TA100) and in theEscherichia colireverse mutation assay with a tryptophan-requiring strain ofEscherichia coli(WP2uvrA). The test was performed in two independent experiments in the presence and absence of S9-mix (rat liver S9-mix induced by a combination of Phenobarbital and β-naphthoflavone).
The study procedures described in the report were based on the most recent OECD and EC guidelines.
In the dose range finding test, Magnesium hydroxide was tested up to concentrations of 5000 µg/plate in the absence and presence of S9-mix in the strains TA100 and WP2uvrA. Magnesium hydroxide did not precipitate on the plates at this dose level. The bacterial background lawn was not reduced at any of the concentrations tested and no biologically relevant decrease in the number of revertants was observed. Results of this dose range finding test were reported as part of the first experiment of the mutation assay.
Based on the results of the dose range finding test, Magnesium hydroxide was tested in the first mutation assay at a concentration range of 100 to 5000 µg/plate in the absence and presence of 5% (v/v) S9-mix in tester strains TA1535, TA1537 and TA98. In an independent repeat of the assay with additional parameters, Magnesium hydroxide was tested at the same concentration range as the first assay in the absence and presence of 10% (v/v) S9-mix in tester strains TA1535, TA1537, TA98, TA100 and WP2uvrA. The bacterial background lawn was not reduced at any of the concentrations tested and no biologically relevant decrease in the number of revertants was observed.
Magnesium hydroxide did not induce a significant dose-related increase in the number of relevant (His+) colonies in tester strain WP2uvrA both in the absence and presence of S9-metabolic activation. The results were confirmed in an independently repeated experiment.
In this study, the negative and strain-specific positive control values were within the laboratory historical control data ranges indicating that the test conditions were adequate and that the metabolic activation system functioned properly.
Based on the results of this study it is concluded that Magnesium hydroxide is not mutagenic inSalmonella typhimuriumreverse mutation assay and in theEscherichia colireverse mutation assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.